Objective Physiologic Measures Characterize Treatable Disease Meet VIP Finally, a proven answer

2010 (113 Slides)

Ritchie C. Shoemaker, MD

Boston, MA
12/1/10

This VIP talk is the first discussion of the successful outcome of the IRB-approved study of VIP in those with CFS.

Preview:

• You will receive a .pdf file via email within 24 hours of placing your order.